The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles

Vaccine

Volumn 24, Issue 9, 2006, Pages 1298-1307

  Pinot De Moira, A ^a,b   Edmunds, W J ^a   Breuer, J ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cost effectiveness; Vaccination; Varicella zoster virus

Indexed keywords

CHICKENPOX VACCINE; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANAMNESIS; ARTICLE; BANGLADESH; BIRTH; CHICKENPOX; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE PREDISPOSITION; FEMALE; HUMAN; INFECTION PREVENTION; MOTHER; NORMAL HUMAN; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; PUERPERIUM; SCREENING; SEROLOGY; UNITED KINGDOM; VACCINATION; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, VIRAL; BANGLADESH; CHICKENPOX; CHICKENPOX VACCINE; COHORT STUDIES; COST-BENEFIT ANALYSIS; EMIGRATION AND IMMIGRATION; FEMALE; GREAT BRITAIN; HERPESVIRUS 3, HUMAN; HUMANS; INTERVIEWS; MASS SCREENING; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SENSITIVITY AND SPECIFICITY;

EID: 32344437810     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.09.028     Document Type: Article

References (39)

1. C.K. Fairley, and E. Miller Varicella-zoster virus epidemiology - a changing scene? J Infect Dis 174 Suppl. 3 1996 S314 S319
2. G. Enders, E. Miller, J. Cradock-Watson, I. Bolley, and M. Ridehalgh Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases Lancet 343 8912 1994 1548 1551
3. E.B. Evans, T.M. Pollock, J.E. Cradock-Watson, and M.K. Ridehalgh Human anti-chickenpox immunoglobulin in the prevention of chickenpox Lancet 1 8164 1980 354 356
4. K. Hanngren, M. Grandien, and G. Granstrom Effect of zoster immunoglobulin for varicella prophylaxis in the newborn Scand J Infect Dis 17 4 1985 343 347
5. The Green Book. In: HM Treasury; 2004.
6. M. Vazquez, P.S. LaRussa, A.A. Gershon, S.P. Steinberg, K. Freudigman, and E.D. Shapiro The effectiveness of the varicella vaccine in clinical practice N Engl J Med 344 13 2001 955 960
7. C.J. White, B.J. Kuter, A. Ngai, C.S. Hildebrand, K.L. Isganitis, and C.M. Patterson Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response Pediatr Infect Dis J 11 1 1992 19 23
8. G. Enders, and E. Miller Varicella and herpes zoster in pregnancy and the newborn A.M. Arvin A.A. Gershon Varicella-zoster virus - virology and clinical management 2000 Cambridge University Press 317 347
9. M. Brisson, N.J. Gay, W.J. Edmunds, and N.J. Andrews Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox Vaccine 20 19-20 2002 2500 2507
10. M. Brisson, W.J. Edmunds, B. Law, N.J. Gay, R. Walld, and M. Brownell Epidemiology of varicella-zoster virus infection in Canada and the United Kingdom Epidemiol Infect 127 2 2001 305 314
11. R.E. Hope Simpson Infectiousness of communicable diseases in the household (Measles, Chickenpox, and Mumps) Lancet 2 1952 549 554
12. Annunziato P, Gershon AA. Primary immunization against varicella. In: Varicella-zoster virus - virology and clinical management; 2000. p. 460-76.
13. Birth Statistics - Review of the registrar general on births and patterns of family building in England and Wales, 2002. Office for National Statistics; 2004.
14. M. Brisson, and W.J. Edmunds Epidemiology of varicella-zoster virus in England and Wales J Med Virol 70 Suppl. 1 2003 S9 S14
15. E. Miller, J.E. Cradock-Watson, and M.K. Ridehalgh Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus Lancet 2 8659 1989 371 373
16. Miller E, Ramsay M, Gibbs T, Vurdien J. Issue of Immunoglobulins by the Health Protection Agency: report for the financial year 2002/2003; 2003.
17. E. Miller, E. Marshal, and J. Vurdien Epidemiology, outcome and control of varicella-zoster infection Rev Med Microbiol 4 1993 222 230
18. Netten A, Curtis L. Unit Costs of Health and Social Care 2002; 2002.
19. N. Devlin, and D. Parkin Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis Health Econ 13 5 2004 437 452
20. British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain; 2004.
21. W.J. Smith, L.A. Jackson, D.H. Watts, and T.D. Koepsell Prevention of chickenpox in reproductive-age women: cost-effectiveness of routine prenatal screening with postpartum vaccination of susceptibles Obstet Gynecol 92 4 Pt 1 1998 535 545
22. T.G. Wreghitt, J. Whipp, C. Redpath, and W. Hollingworth An analysis of infection control of varicella-zoster virus infections in Addenbrooke's Hospital Cambridge over a 5-year period Epidemiol Infect 117 1 1996 165 171
23. M. Brisson, and W.J. Edmunds Varicella vaccination in England and Wales: cost-utility analysis Arch Dis Child 88 10 2003 862 869
24. J.C. Glantz, and A.I. Mushlin Cost-effectiveness of routine antenatal varicella screening Obstet Gynecol 91 4 1998 519 528
25. Hospital Episodes Statistics 2000/2002. Department of Health; 2002.
26. G.P. Garnett, M.J. Cox, D.A. Bundy, J.M. Didier, and J. St Catharine The age of infection with varicella-zoster virus in St. Lucia, West Indies Epidemiol Infect 110 2 1993 361 372
27. I.R. Hastie Varicella-zoster virus affecting immigrant nurses Lancet 2 8186 1980 154 155
28. H. Kjersem, and S. Jepsen Varicella among immigrants from the tropics, a health problem Scand J Soc Med 18 3 1990 171 174
29. B.W. Lee Review of varicella-zoster seroepidemiology in India and Southeast Asia Trop Med Int Health 3 11 1998 886 890
30. Z. Maretic, and M.P.M. Cooray Comparison between chickenpox in a tropical and a European country J Trop Med Hyg 66 1963 311 315
31. N. Roberts, G.J. Peek, N. Jones, R.K. Firmin, and D. Elbourne Deaths from chickenpox. Healthcare workers should not be forgotten BMJ 324 7337 2002 610
32. E.P. Kubeyinje, C.S. Belagavi, and S. Desai Ethnic differences in the severity of varicella in adults in northern Saudi Arabia East Afr Med J 74 11 1997 727 728
33. Table S015: Country of birth by sex and age. Office for National Statistics; 2003
34. E. MacMahon, L.J. Brown, S. Bexley, D.C. Snashall, and D. Patel Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study BMJ 329 7465 2004 551 552
35. A.A. Gershon, P. LaRussa, S. Steinberg, N. Mervish, S.H. Lo, and P. Meier The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox J Infect Dis 173 2 1996 450 453
36. M. Vazquez, P.S. LaRussa, A.A. Gershon, S.P. Steinberg, K. Freudigman, and E.D. Shapiro Effectiveness over time of varicella vaccine JAMA 291 7 2004 851 855
37. B.R. Lee, S.L. Feaver, C.A. Miller, C.W. Hedberg, and K.R. Ehresmann An elementary school outbreak of varicella attributed to vaccine failure: policy implications J Infect Dis 190 3 2004 477 483 Epub 2004, June 2029
38. J.F. Seward, J.X. Zhang, T.J. Maupin, L. Mascola, and A.O. Jumaan Contagiousness of varicella in vaccinated cases: a household contact study JAMA 292 6 2004 704 708
39. B.D. Tugwell, L.E. Lee, H. Gillette, E.M. Lorber, K. Hedberg, and P.R. Cieslak Chickenpox outbreak in a highly vaccinated school population Pediatrics 113 3 Pt 1 2004 455 459